Moderna, Inc. 8-K

What Happened
Moderna, Inc. announced on January 5, 2026 that it issued a letter to shareholders and filed a Form 8-K (Item 7.01) to disclose the communication under Regulation FD. The letter is attached to the filing as Exhibit 99.1 and is incorporated by reference into the 8-K. The report was signed by Shannon Thyme Klinger, Chief Legal Officer.

Key Details

• Filing date: January 5, 2026 (Form 8-K, Item 7.01 — Regulation FD Disclosure).
• Exhibit included: 99.1 — Letter dated January 5, 2026, from Moderna to its shareholders.
• Administrative exhibits: Inline XBRL cover page file included as Exhibit 104.
• Signed by: Shannon Thyme Klinger, Chief Legal Officer.

Why It Matters
This 8-K is a public disclosure of a shareholder communication—made under Regulation FD to ensure material information was shared broadly. The filing itself does not report earnings, financial results, management changes, or other corporate transactions; investors should read the attached shareholder letter (Exhibit 99.1) for any material content or updates conveyed by the company.